Shares of the medical device maker Boston Scientific Corp. declined Tuesday, a day after the company said it had agreed to buy Rhythmia Medical Inc., a Burlington developer of medical software. Boston Scientific will pay about $90 million upfront and make as much as $175 million in milestone payments over five years. Rhythmia develops mapping and navigation software for use in cardiac catheter ablations, a way to treat abnormal heart rhythms, and other electrophysi0logy procedures, including atrial fibrillation and atrial flutter.
Boston Scientific Corp.’s shares slip
You have reached the limit of 10 free articles in a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than 25¢ a week